CARE WATCH
RAPPORE / 2025 GREENSPACE AWARD FOR INNOVATIVE MEASUREMENT-BASED CARETHE QUESTION: WHAT HAPPENS WHEN TREATMENT STALLS?

Company / Mental health care

Rappore asks the question a refill cannot answer

When mental health treatment stops helping, another prescription may be the wrong next step. Rappore builds its virtual clinic around coordinated care, careful diagnosis, and the discipline of checking what changed.

A refill answers a small question: is there more medicine in the bottle? A patient whose anxiety has returned is asking something larger. Why did the treatment help, then stop? Was it the dose, the diagnosis, the sleep, the side effects, or something happening elsewhere in life? Rappore, a New York-based virtual mental health clinic, has built its proposition around that gap between renewing a prescription and reconsidering a person.

The useful bits
  • Adult therapy and psychiatry, with coordinated care when both are needed.
  • Employed clinicians, structured supervision, and a published review process for stalled treatment.
  • Insurance and self-pay options; availability and costs depend on the service and plan.

The company’s interesting feature is organizational. A therapist and a prescriber can work inside the same clinic, toward the same plan. For anyone who has had to carry an explanation from one professional to another, that sounds almost suspiciously ordinary. Ordinary, however, is precisely what fragmented care can make difficult.

A soldier, a psychiatrist, and a coordination problem

Brian Kinsella came to this problem through military mental health. He co-founded Stop Soldier Suicide before building Rappore, which dates its founding to 2018. In a 2024 Goldman Sachs alumni interview, he described applying that experience to civilian care. Geography, affordability, accessibility, and stigma could all stand between someone and treatment. Getting an appointment was only part of the task.

His clinical counterpart was Frederic I. Kass, known as Fred, who had served in leadership at Columbia psychiatry. The current Rappore team page lists Kass as co-founder and chief medical officer, and Kinsella as co-founder and chairman. Their pairing helps explain the business: use technology to deliver care while preserving the clinical organization behind it.

Rappore co-founder Brian E. KinsellaRappore co-founder Frederic I. Kass
Two résumés, one coordination problem. Brian Kinsella, left, and Fred Kass bring different histories to the same virtual clinic. Portraits: Rappore.

Kinsella said the technology reduced insurance-processing and clerical burdens so clinicians could spend more attention on patients. The aim was comprehensive, measurable improvement over continuing care. That is a different product promise from simply making a directory of professionals easier to search.

The fingerprint is a starting point

Rappore offers adult psychiatry, adult psychotherapy, and a combined path. Its advertised teen psychiatry service covers ages 15 to 17. The broader services pages list New York, New Jersey, Connecticut, and Florida; patients need to confirm that their intended service and clinician are available where they live.

The company calls its structured assessment the Mental Health Fingerprint. The memorable name belongs to a practical idea: symptoms and stressors should help inform matching, treatment, and subsequent review. Rappore describes looking at sleep stability, concentration, irritability, avoidance, and quality of life alongside conventional symptom measures. A trademark does not make an assessment infallible; the useful question is how its findings change the next conversation.

Psychiatry begins with evaluation before a medication decision. Therapy draws from several approaches, including cognitive behavioral, dialectical behavioral, psychodynamic, and attachment-based work. When a patient receives both, the clinic’s model allows the therapist and prescriber to coordinate. Rappore says its clinicians are employees, with continuity and supervision built into that arrangement.

“A brief screening questionnaire is not a clinical evaluation.”Rappore’s published care standards

Feeling better has more than one meaning

A symptom score can improve while ordinary life remains narrowed. Someone may feel less anxious yet still avoid friends, struggle at work, or abandon responsibilities. Rappore’s outcomes framework separates symptoms from functioning and safety. It names PHQ-9 for depression, GAD-7 for anxiety, and a brief functioning measure such as WSAS. The interpretation remains a clinician’s job.

In December 2025, Greenspace Health recognized Rappore for Most Innovative MBC Implementation in its inaugural measurement-based care awards. Greenspace highlighted the integration of assessments into clinical workflow and a transparent patient process. This was recognition from its measurement-platform partner for implementation, with a specific category and a specific meaning.

The home page also advertises reductions in anxiety and depression and improved daily function after 45 days of active care. Those are company-reported figures, rather than a forecast for a new patient. The more useful distinction is the clinic’s willingness to describe what it checks when improvement does not arrive.

When the plan needs another look

Rappore publishes seven safety protocols. Their underlying argument is that clinical judgment needs a structure around it: an evaluation before prescribing, a decision about whether telehealth is appropriate, prescribing safeguards, supervision, repeated measurement, reassessment, and attention to changes between visits. The reader gets something more concrete than a promise to be compassionate.

When treatment stalls, the published pathway asks clinicians to revisit diagnostic fit, medical contributors, adherence, tolerability, and new stressors. Possible next steps include adjusting treatment, changing the therapy strategy, or referring elsewhere. Rather than treating every disappointment as a request for more medication, the process makes room to ask whether the original explanation still fits.

The clinic has particular depth in women’s mental health. Its condition pages address PMDD and perimenopause-related mood changes, and its standards include reproductive context in assessment and prescribing decisions. For patients, the practical implication is that life stage belongs in the conversation about what changed. It need not remain a footnote beneath a symptom checklist.

The bill is part of the appointment

Rappore earns money through clinical visits paid by insurance or patients. It lists major insurers and Medicare credentialing; its FAQs say it does not accept Medicaid. The actual price depends on the appointment and exact plan. Recognizing an insurer’s logo is insufficient: deductibles, copays, coinsurance, and network participation still determine what a patient owes. Rappore says visit costs are shown beforehand.

The model suits ongoing outpatient care within the clinic’s geographic and clinical scope. Telehealth requires a private setting and a usable connection. Rappore screens for needs beyond that scope and describes referral pathways; its terms exclude emergency and urgent medical matters. Coordination is valuable, but the right level of care still comes first.

There is a question worth borrowing whether or not you book with Rappore: what happens if I stop improving? Ask who reviews the case, what gets measured, and when the plan changes. A provider’s answer reveals how care behaves after the welcome message. That is where a pleasant appointment becomes an accountable course of treatment.